文献速递头颈部肿瘤放疗

局部晚期头颈癌患者喉部亚结构与误吸的剂量-体积关系

Dose-volume relationship for laryngeal substructures and aspiration in patients with locally advanced head-and-neck cancer.
PubMed 文献 · Radiat Oncol · 2019-03-18

这项前瞻性研究纳入49例III/IV期头颈鳞癌患者(最终分析29例),接受基于IMRT的放化疗,于放化疗前及放化疗后3、6、9、12、24个月行视频荧光造影,分析12个喉部亚结构剂量-体积参数与1年误吸的关系。结果显示杓会厌襞平均剂量与12个月误吸相关性最高,多因素分析有统计学意义(p=0.025);杓会厌襞平均剂量≥6500 cGy与1年误吸风险增加相关(+LR 2.81,PPV 60%,NPV 92.9%,RR 8.4)。作者指出这些是产生假设的数据,需进一步研究和在更大患者子集中验证。

要点

  • 杓会厌襞平均剂量与放化疗后12个月误吸相关性最高,多因素分析p=0.025。
  • 杓会厌襞平均剂量≥6500 cGy与1年误吸风险增加相关(RR 8.4)。
  • 该结果为产生假设的数据,需进一步研究和在更大患者子集中验证。

核心结论

  • 在本分析中,杓会厌襞平均剂量与1年误吸风险增加相关。
  • 作者指出这些是产生假设的数据,需进一步研究和在更大患者子集中验证。

研究设计与样本

  • 前瞻性研究,49例III/IV期头颈鳞状细胞癌患者前瞻性入组,经IRB批准并获联邦资助。
  • 所有患者接受基于IMRT的放化疗,计划于放化疗前及放化疗后3、6、9、12、24个月行视频荧光造影。
  • 每例患者勾画12个喉部亚结构:甲状软骨、环状软骨、会厌总长、舌骨上会厌、舌骨下会厌、全喉、声门上喉、声门下喉、声门喉、杓状软骨、杓会厌襞、舌会厌襞。
  • 排除后最终分析纳入29例患者。
  • 采用logistic回归分析放化疗后1年误吸发生率与喉部亚结构剂量-体积数据的相关性。

主要发现

  • 中位年龄54岁,79%为非吸烟者。
  • 肿瘤部位包括口咽(22例)、原发不明(6例)、下咽(1例)。
  • 放化疗后1年,10/29(34%)在视频荧光造影中显示误吸。
  • 杓会厌襞剂量与12个月误吸相关性最高,多因素分析有统计学意义(p=0.025)。
  • 杓会厌襞平均剂量≥6500 cGy与1年误吸风险增加相关(+LR 2.81,PPV 60%,NPV 92.9%,RR 8.4)。

关键数值与推荐

  • 杓会厌襞平均剂量切点6500 cGy或更高与1年误吸风险增加相关(+LR 2.81,PPV 60%,NPV 92.9%,RR 8.4)。
  • 杓会厌襞剂量与12个月误吸在多因素分析中p=0.025。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 作者指出这些是产生假设的数据,需进一步研究和在更大患者子集中验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Literature has shown a significant relationship between radiation dose to the larynx and swallowing disorders. We prospectively studied the dose-volume relationship for larynx substructures and aspiration. METHODS: Forty nine patients with stage III/IV head-and-neck (H&N) squamous cell carcinoma were prospectively enrolled in this IRB-approved, federally funded study. All patients received IMRT-based chemoradiation therapy (CRT) and were scheduled for videofluorography (VFG) prior to CRT and at 3, 6, 9, 12, and 24 months post-CRT. Twelve laryngeal substructures were contoured in each patient: thyroid cartilage, cricoid cartilage, total epiglottis, suprahyoid epiglottis, infrahyoid epiglottis, total larynx, supraglottic larynx, subglottic larynx, glottic larynx, arytenoids, aryepiglottic (AE) folds, and glossoepiglottic fold. After exclusions, 29 patients were included in the final analysis. Incidence of aspiration at 1 year following CRT was correlated with dose-volume data to laryngeal substructures using logistic regression. RESULTS: The median age was 54 years with 79% being non-smokers. Tumor sites included oropharynx (22), unknown primary (6), and hypopharynx (1). One year following CRT, 10/29 (34%) showed aspiration on VFG. Dose to the AE folds showed the highest correlation with aspiration at 12 months and was significant on multivariate analysis (p = 0.025). A mean dose cutpoint of 6500 cGy or higher to the AE folds was associated with an increased risk of aspiration at 1 year [positive likelihood ratio (+LR) 2.81, positive predictive value (PPV) 60%, negative predictive value (NPV) 92.9%, relative risk (RR) 8.4]. CONCLUSIONS: In this analysis, mean dose to the AE folds was associated with an increased risk of aspiration at 1 year. However, these are hypothesis-generating data that require further research and validation in a larger patient subset.

来源:Radiat Oncol,查看原文。版权归原作者所有。

引用

  1. Petras KG, Rademaker AW, Refaat T, et al. Dose-volume relationship for laryngeal substructures and aspiration in patients with locally advanced head-and-neck cancer. Radiat Oncol. 2019. PMID: 30885235. doi:10.1186/s13014-019-1247-7

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。